|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 11-19-2004
NEW YORK (Reuters Health) - A part of the brain involved in both drug craving and judgment appears to be smaller in cocaine addicts than in healthy people, researchers have found.
NEW YORK (Reuters Health) - In the US, many mothers who have "no indicated risk" for a difficult vaginal birth are having caesarean deliveries -- and the rate is rising year by year -- according to a report in the British Medical Journal.
NEW YORK (Reuters Health) - Women undergoing a treatment called thermal balloon ablation for excessive menstrual bleeding can be safely treated on an outpatient basis, UK researchers.
LONDON (Reuters) - A low-cost antibiotic which has performed well in tests should be given to all HIV children in developing countries to prevent infections such as pneumonia and reduce deaths, scientists said on Friday.
WASHINGTON/NEW YORK (Reuters) - A U.S. Food and Drug Administration reviewer who has accused the agency of being lax in monitoring drug safety on Thursday said five medicines on the market need closer scrutiny.
ATLANTA (Reuters) - An unexpectedly high number of U.S. soldiers injured in the Middle East and Afghanistan are testing positive for a rare, hard-to-treat blood infection in military hospitals, Army doctors reported on Thursday.
WASHINGTON (Reuters) - Painkillers suspected of causing fatal heart disease may act by starting the process of hardening the arteries, researchers proposed on Thursday.
WASHINGTON (Reuters) - The U.S. Food and Drug Administration failed to protect the public from Merck & Co. Inc.'s MRK.N now-withdrawn painkiller Vioxx and is incapable of guarding America from dangerous drugs, a veteran FDA researcher told Congress on Thursday.
GENEVA (Reuters) - Hetero Drugs has withdrawn all six of its generic antiretroviral drugs from the WHO's list of approved drugs following concerns about their laboratory tests, the World Health Organization (WHO) said Friday.
UNITED NATIONS (Reuters) - A U.S.-led campaign to ban cloning of human embryos, including for stem cell research, crumbled on Friday as a divided United Nations prepared to abandon the initiative.
|
|
